GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Freeline Therapeutics Holdings PLC (NAS:FRLN) » Definitions » FCF Yield %

Freeline Therapeutics Holdings (Freeline Therapeutics Holdings) FCF Yield % : -465.15 (As of Jun. 08, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Freeline Therapeutics Holdings FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Freeline Therapeutics Holdings's Trailing 12-Month Free Cash Flow is $-68.79 Mil, and Market Cap is $28.46 Mil. Therefore, Freeline Therapeutics Holdings's FCF Yield % for today is -465.15%.

The historical rank and industry rank for Freeline Therapeutics Holdings's FCF Yield % or its related term are showing as below:

FRLN' s FCF Yield % Range Over the Past 10 Years
Min: -538.83   Med: -468.58   Max: -465.15
Current: -465.15


During the past 5 years, the highest FCF Yield % of Freeline Therapeutics Holdings was -465.15%. The lowest was -538.83%. And the median was -468.58%.

FRLN's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -13.915 vs FRLN: -465.15

Freeline Therapeutics Holdings's FCF Margin % for the quarter that ended in Sep. 2023 was -173,580.00%.


Freeline Therapeutics Holdings FCF Yield % Historical Data

The historical data trend for Freeline Therapeutics Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Freeline Therapeutics Holdings FCF Yield % Chart

Freeline Therapeutics Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
FCF Yield %
- - -14.89 -157.53 -275.54

Freeline Therapeutics Holdings Quarterly Data
Dec18 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -152.57 -307.07 -254.09 -623.79 -185.26

Competitive Comparison of Freeline Therapeutics Holdings's FCF Yield %

For the Biotechnology subindustry, Freeline Therapeutics Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Freeline Therapeutics Holdings's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Freeline Therapeutics Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Freeline Therapeutics Holdings's FCF Yield % falls into.



Freeline Therapeutics Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Freeline Therapeutics Holdings's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-85.238 / 30.93542385
=-275.54%

Freeline Therapeutics Holdings's annualized FCF Yield % for the quarter that ended in Sep. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-8.679 * 4 / 18.739185
=-185.26%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Freeline Therapeutics Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Freeline Therapeutics Holdings FCF Yield % Related Terms

Thank you for viewing the detailed overview of Freeline Therapeutics Holdings's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Freeline Therapeutics Holdings (Freeline Therapeutics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
Gunnels Wood Road, Sycamore House, Stevenage, Hertfordshire, GBR, SG1 2BP
Freeline Therapeutics Holdings PLC is a clinical-stage biotechnology company developing transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its lead product candidates are FLT180a for the treatment of hemophilia B, FLT190 for the treatment of Fabry disease and FLT201 for the treatment of Gaucher disease Type 1.